Statin Therapy to Improve Outcome of COVID-19 Patients: Useful or Not Useful?
- PMID: 36294766
- PMCID: PMC9605438
- DOI: 10.3390/jpm12101627
Statin Therapy to Improve Outcome of COVID-19 Patients: Useful or Not Useful?
Abstract
About one year ago, the journal published a large population-based cohort study from South Korea investigating the potential benefits associated with statins at preventing severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection or improving the outcome of hospitalized coronavirus disease-2019 (COVID-19) patients [...].
Conflict of interest statement
The author declares no conflict of interest.
References
-
- Raisi-Estabragh Z., McCracken C., Bethell M.S., Cooper J., Cooper C., Caulfield M.J., Munroe P.B., Harvey N.C., Petersen S.E. Greater risk of severe COVID-19 in Black, Asian and Minority Ethnic populations is not explained by cardiometabolic, socioeconomic or behavioural factors, or by 25(OH)-vitamin D status: Study of 1326 cases from the UK Biobank. J. Public Health. 2020;42:451–460. doi: 10.1093/pubmed/fdaa095. - DOI - PMC - PubMed
-
- Rahimibashar F., Sedighi L., Shahriary A., Reiner Z., Pourhoseingholi M.A., Mirmomeni G., Jouzdani A.F., Vahedian-Azimi A., Jamialahmadi T., Sahebkar A. Is there any association between plasma lipid profile and severity of COVID-19? Clin. Nutr. ESPEN. 2022;49:191–196. doi: 10.1016/j.clnesp.2022.04.026. - DOI - PMC - PubMed
-
- Palaiodimos L., Kokkinidis D.G., Li W., Karamanis D., Ognibene J., Arora S., Southern W.N., Mantzoros C.S. Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism. 2020;108:154262. doi: 10.1016/j.metabol.2020.154262. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
